References
- Byrne S, Walsh C, Lynch C, Bede P, Elamin M, Kenna K, . Rate of familial amyotrophic lateral sclerosis: a systematic review and meta-analysis. J Neurol Neurosurg Psychiatry. 2010 Nov 3. (Epub ahead of print).
- Andersen PM, Sims KB, Xin WW, Kiely R, O'Neill G, Ravits J, . Sixteen novel mutations in the Cu/Zn superoxide dismutase gene in amyotrophic lateral sclerosis: a decade of discoveries, defects and disputes. Amyotroph Lateral Scler Other Motor Neuron Disord. 2003;4:62–73.
- Marucci G, Morandi L, Bartolomei I, Salvi F, Pession A, Righi A, . Amyotrophic lateral sclerosis with mutation of the Cu/Zn superoxide dismutase gene (SOD1) in a patient with Down syndrome. Neuromuscul Disord. 2007;17:673–6.
- Dubowitz V, Sewry CA. Muscle biopsy. A practical approach. Philadelphia: Saunders Elsevier; 2007, 75–123.
- Roy A, Kucukural A, Zhang Y. I-TASSER: a unified platform for automated protein structure and function prediction. Nat Protoc. 2010;5:725–38.
- Brunham LR, Singaraja RR, Pape TD, Kejariwal A, Thomas PD, Hayden MR. Accurate prediction of the functional significance of single nucleotide polymorphisms and mutations in the ABCA1 gene. PLoS Genet. 2005;1:83.
- Adzhubei IA, Schmidt S, Peshkin L, Ramensky VE, Gerasimova A, Bork P, . A method and server for predicting damaging missense mutations. Nat Methods. 2010; 7:248–9.
- Hart PJ. Pathogenic superoxide dismutase structure, folding, aggregation and turnover. Curr Opin Chem Biol. 2006;10:131–8.
- Tiwari A, Hayward LJ. Mutant SOD1 instability: implications for toxicity in amyotrophic lateral sclerosis. Neurodegener Dis. 2005;2:115–27.
- Banci L, Bertini I, Cramaro F, del Conte R, Rosato A, Viezzoli MS. Backbone dynamics of human Cu/Zn superoxide dismutase and of its monomeric F50E/G51E/E133Q mutant: the influence of dimerization on mobility and function. Biochemistry. 2000;39:9108–18.